Loading...
•
Dec 31, 2020
Pediatrix Q4 2020 Earnings Report
Mednax reported Q4 2020 earnings impacted by the COVID-19 pandemic but showed enhanced efficiency and financial strength.
Key Takeaways
Mednax, Inc. reported earnings from continuing operations of $0.05 per share for the three months ended December 31, 2020. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.25. Net revenue for the quarter was $417 million and income from continuing operations was $4 million.
Net revenue of $417 million.
Income from continuing operations of $4 million.
Net loss of $64 million.
Adjusted EBITDA of $58 million.
Forward Guidance
Mednax's results from operations in the 2021 first quarter, when compared on a sequential basis to the 2020 fourth quarter, will be affected by annual seasonality. These recurring items reduce Mednax’s net income, Adjusted EBITDA and Adjusted EPS for the first quarter of each year, relative to other quarters throughout the year.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...